CompletedEUCTR 2020-000405-83
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaBipolarityHistorical research record
- Countries
- Bulgaria, Poland
- Sponsor
- Vanda Pharmaceuticals Inc.
Not recruitingEUCTR 2010-023992-24
This study isn't currently recruiting.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumBipolarityHistorical research record
- Countries
- Belgium, Germany, Hungary, + 1 other
- Sponsor
- University of Leipzig
CompletedNCT05956340
Official study titleComputational Analysis of Spoken Language in Mania
This study has finished and is no longer accepting participants.
In RochesterBipolarityBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- Mayo Clinic
CompletedNCT00643123
Official study titleA Double-Blind, Placebo Controlled Augmentation Study With Allopurinol for Treatment Resistant Mania
This study has finished and is no longer accepting participants.
In Los AngelesBipolarityMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Cedars-Sinai Medical Center
CompletedNCT00208195
This study has finished and is no longer accepting participants.
In OmahaBipolarityMedication studyAges 19–65
- Countries
- United States
- Sponsor
- Creighton University
CompletedNCT00893581
This study has finished and is no longer accepting participants.
In CincinnatiBipolarityMedication studyAges 12–17
- Countries
- United States
- Sponsor
- University of Cincinnati
CompletedNCT00206778
Official study titleA Randomized Open-Label 6 Month Acute and Maintenance Trial of Lamotrigine vs. Standard of Care Sodium Valproate Monotherapy for Treatment of Mixed Mania.
This study has finished and is no longer accepting participants.
In New YorkBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Beth Israel Medical Center
CompletedNCT01191918
Official study titleA Double-Blind, Placebo-Controlled Evaluation of The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18–60
- Countries
- Sponsor
- Shanghai Mental Health Center
CompletedNCT01818622
Official study titleVirtual Darkness as Additive Treatment in Mania- a Randomized Controlled Trial
This study has finished and is no longer accepting participants.
Multiple locations, including HaugesundBipolarityDevice studyAges 18–70
- Countries
- Norway
- Sponsor
- Helse Fonna
TerminatedNCT00329108
Official study titleA Multicenter, Randomized, Double-Blind, Parallel Group Study, Comparing The Efficacy And Tolerability Of Ziprasidone (Zeldox, Geodon) vs. Olanzapine (Zyprexa) In The Treatment And Maintenance Of Response In Patients With Acute Mania
This study ended early.
Multiple locations, including AachenBipolarityMedication studyAges 18–65
- Countries
- Germany, Greece, Italy, + 2 others
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
CompletedNCT01498770
Official study titleAn Observational Drug Utilization Study of SYCREST^® (Asenapine) in the United Kingdom
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityObservational study
- Countries
- Sponsor
- Organon and Co
CompletedNCT03181698
Official study titleDifferences in Voxel-based Morphometry of Different Brain Structures in Patients With Mood Disorder Bipolar Mania in Comparison to Morphometry of Nrmal Controls
This study has finished and is no longer accepting participants.
In AsyutBipolarityObservational study
- Countries
- Egypt
- Sponsor
- Assiut University